Last 12 months
Inside the activity.
1 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2022 Filed Feb 2, 2022 22:00 UTC |
Tross Stuart AChief People & Workpl Officer
|
PurchaseCommon Stock, $0.01 Par Value | 4,254 | $3.17 | $13,485.18 |
DisclosureSEC source: 0001209191-22-006417 · doc4.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624,785 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective January 31, 2022. Read SEC document |
| January 31, 2022 Filed Feb 10, 2022 02:00 UTC Amendment |
Galindo AlejandroChief Commercial Officer
|
PurchaseCommon Stock, $0.01 Par Value | 1,804 | $3.17 | $5,718.68 |
DisclosureSEC source: 0001209191-22-008268 · doc4a.xml · nonDerivative · entry 1 Galindo Alejandro · CIK 0001821447 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,790 F1 · shares: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2022. The amended number of shares purchased were limited by Section 423(b)(8) of the Code. Read SEC document |
| January 31, 2022 Filed Feb 10, 2022 02:00 UTC Amendment |
Castagna MichaelDirector · Chief Executive Officer
|
PurchaseCommon Stock, $0.01 Par Value | 1,804 | $3.17 | $5,718.68 |
DisclosureSEC source: 0001209191-22-008267 · doc4a.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,505,098 F1 · shares: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2022. The amended number of shares purchased were limited by Section 423(b)(8) of the Code. Read SEC document |
| January 31, 2022 Filed Feb 10, 2022 02:00 UTC Amendment |
Tross Stuart AChief People & Workpl Officer
|
PurchaseCommon Stock, $0.01 Par Value | 2,254 | $3.17 | $7,145.18 |
DisclosureSEC source: 0001209191-22-008266 · doc4a.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 622,785 F1 · shares: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2022. The amended number of shares purchased were limited by Section 423(b)(8) of the Code. Read SEC document |
| January 31, 2022 Filed Aug 25, 2022 01:00 UTC Amendment |
Binder Steven B.Chief Financial Officer
|
GrantCommon Stock, $0.01 Par Value | 711 | $3.17 | $2,253.87 |
DisclosureSEC source: 0001209191-22-047427 · doc4a.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,178 F1 · kind: This Form 4 is being amended to correct the transaction code. The securities were purchased through the Company's Employee Stock Purchase Plan effective January 31, 2022. Read SEC document |
| January 31, 2022 Filed Aug 25, 2022 01:00 UTC Amendment |
Tross Stuart AChief People & Workpl Officer
|
GrantCommon Stock, $0.01 Par Value | 2,254 | $3.17 | $7,145.18 |
DisclosureSEC source: 0001209191-22-047424 · doc4a.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 622,785 F1 · kind: This Form 4 is being amended to correct the transaction code. The securities were purchased through the Company's Employee Stock Purchase Plan effective January 31, 2022. Read SEC document |
| January 31, 2022 Filed Aug 25, 2022 01:00 UTC Amendment |
Castagna MichaelDirector · Chief Executive Officer
|
GrantCommon Stock, $0.01 Par Value | 1,804 | $3.17 | $5,718.68 |
DisclosureSEC source: 0001209191-22-047422 · doc4a.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,505,098 F1 · kind: This Form 4 is being amended to correct the transaction code. The securities were purchased through the Company's Employee Stock Purchase Plan effective January 31, 2022. Read SEC document |
| January 31, 2022 Filed Aug 25, 2022 01:00 UTC Amendment |
Galindo AlejandroEVP Endocrine Business Unit
|
GrantCommon Stock, $0.01 Par Value | 1,804 | $3.17 | $5,718.68 |
DisclosureSEC source: 0001209191-22-047421 · doc4a.xml · nonDerivative · entry 1 Galindo Alejandro · CIK 0001821447 · EVP Endocrine Business Unit 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,790 F1 · kind: This Form 4 is being amended to correct the transaction code. The securities were purchased through the Company's Employee Stock Purchase Plan effective January 31, 2022. Read SEC document |
| August 27, 2021 Filed Aug 28, 2021 01:00 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 35,358 | $4.91 | $173,607.78 |
DisclosureSEC source: 0001209191-21-053768 · doc4.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,503,294 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 27, 2021 Filed Aug 28, 2021 01:01 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
Tax withholdingCommon Stock, $.01 Par Value | 14,177 | $4.91 | $69,609.07 |
DisclosureSEC source: 0001209191-21-053771 · doc4.xml · nonDerivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 553,214 F2 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 27, 2021 Filed Aug 28, 2021 01:01 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
SaleCommon Stock, $.01 Par Value | 4,100 | $4.64 | $19,024.00 |
DisclosureSEC source: 0001209191-21-053771 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567,391 F1 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 27, 2021 Filed Aug 28, 2021 01:01 UTC |
Galindo AlejandroChief Commercial Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 9,616 | $4.91 | $47,214.56 |
DisclosureSEC source: 0001209191-21-053770 · doc4.xml · nonDerivative · entry 1 Galindo Alejandro · CIK 0001821447 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537,986 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 27, 2021 Filed Aug 28, 2021 01:01 UTC |
Kocinsky JosephChief Technology Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 9,983 | $4.91 | $49,016.53 |
DisclosureSEC source: 0001209191-21-053769 · doc4.xml · nonDerivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563,429 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 27, 2021 Filed Aug 28, 2021 01:00 UTC |
Tross Stuart AChief People & Workpl Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 14,177 | $4.91 | $69,609.07 |
DisclosureSEC source: 0001209191-21-053767 · doc4.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 620,531 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 27, 2021 Filed Aug 28, 2021 01:00 UTC |
Binder Steven B.Chief Financial Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 14,177 | $4.91 | $69,609.07 |
DisclosureSEC source: 0001209191-21-053765 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533,467 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 00:00 UTC |
Binder Steven B.Chief Financial Officer
|
PurchaseCommon Stock, $0.01 Par Value | 748 | $2.99 | $2,236.52 |
DisclosureSEC source: 0001209191-21-049138 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 547,644 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective July 31, 2021. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 00:00 UTC |
Tross Stuart AChief People & Workpl Officer
|
PurchaseCommon Stock, $0.01 Par Value | 4,476 | $2.99 | $13,383.24 |
DisclosureSEC source: 0001209191-21-049139 · doc4.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,708 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective July 31, 2021. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 00:00 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
PurchaseCommon Stock, $0.01 Par Value | 5,000 | $2.99 | $14,950.00 |
DisclosureSEC source: 0001209191-21-049136 · doc4.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,538,652 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective July 31, 2021 representing the maximum allowable under the Plan for this period. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 00:00 UTC |
Galindo AlejandroChief Commercial Officer
|
PurchaseCommon Stock, $0.01 Par Value | 5,000 | $2.99 | $14,950.00 |
DisclosureSEC source: 0001209191-21-049137 · doc4.xml · nonDerivative · entry 1 Galindo Alejandro · CIK 0001821447 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 547,602 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective July 31, 2021 representing the maximum allowable under the Plan for this period. Read SEC document |
| May 20, 2021 Filed May 21, 2021 01:00 UTC |
Consiglio Ronald JDirector
|
GrantRestricted Stock Unit · Derivative | 11,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034726 · doc4.xml · derivative · entry 2 CONSIGLIO RONALD J · CIK 0001232088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,338 Underlying: Common Stock · 11,338 shares Expires 2031-05-20 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F3 · derivative.exercise_date: Annual Retainer: Award granted in lieu of annual cash retainer payment. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 20, 2021 Filed May 21, 2021 01:00 UTC |
Consiglio Ronald JDirector
|
GrantRestricted Stock Unit · Derivative | 33,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034726 · doc4.xml · derivative · entry 1 CONSIGLIO RONALD J · CIK 0001232088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,860 Underlying: Common Stock · 33,860 shares Expires 2031-05-20 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 20, 2021 Filed May 21, 2021 01:00 UTC |
Grancio JenniferDirector
|
GrantRestricted Stock Unit · Derivative | 33,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034725 · doc4.xml · derivative · entry 1 Grancio Jennifer · CIK 0001807888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,860 Underlying: Common Stock · 33,860 shares Expires 2031-05-20 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 20, 2021 Filed May 21, 2021 01:00 UTC |
Friedman Michael ADirector
|
GrantRestricted Stock Unit · Derivative | 33,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034724 · doc4.xml · derivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,860 Underlying: Common Stock · 33,860 shares Expires 2031-05-20 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 20, 2021 Filed May 21, 2021 01:00 UTC |
Kay SabrinaDirector
|
GrantRestricted Stock Unit · Derivative | 33,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034723 · doc4.xml · derivative · entry 1 Kay Sabrina · CIK 0001835895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,860 Underlying: Common Stock · 33,860 shares Expires 2031-05-20 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 20, 2021 Filed May 21, 2021 01:00 UTC |
MUNDKUR CHRISTINEDirector
|
GrantRestricted Stock Unit · Derivative | 33,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034722 · doc4.xml · derivative · entry 1 MUNDKUR CHRISTINE · CIK 0001237264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,860 Underlying: Common Stock · 33,860 shares Expires 2031-05-20 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 20, 2021 Filed May 21, 2021 01:00 UTC |
Shannon James SamuelDirector
|
GrantRestricted Stock Unit · Derivative | 11,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034721 · doc4.xml · derivative · entry 2 Shannon James Samuel · CIK 0001485417 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,338 Underlying: Common Stock · 11,338 shares Expires 2031-05-20 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F3 · derivative.exercise_date: Annual Retainer: Award granted in lieu of annual cash retainer payment. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 20, 2021 Filed May 21, 2021 01:00 UTC |
Shannon James SamuelDirector
|
GrantRestricted Stock Unit · Derivative | 33,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034721 · doc4.xml · derivative · entry 1 Shannon James Samuel · CIK 0001485417 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,860 Underlying: Common Stock · 33,860 shares Expires 2031-05-20 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 20, 2021 Filed May 21, 2021 01:00 UTC |
KRESA KENTDirector
|
GrantRestricted Stock Unit · Derivative | 11,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034720 · doc4.xml · derivative · entry 2 KRESA KENT · CIK 0001197571 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,338 Underlying: Common Stock · 11,338 shares Expires 2031-05-20 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F3 · derivative.exercise_date: Annual Retainer: Award granted in lieu of annual cash retainer payment. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 20, 2021 Filed May 21, 2021 01:00 UTC |
KRESA KENTDirector
|
GrantRestricted Stock Unit · Derivative | 33,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034720 · doc4.xml · derivative · entry 1 KRESA KENT · CIK 0001197571 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,860 Underlying: Common Stock · 33,860 shares Expires 2031-05-20 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 20, 2021 Filed May 21, 2021 01:00 UTC |
HOOPER ANTHONY CDirector
|
GrantRestricted Stock Unit · Derivative | 11,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034719 · doc4.xml · derivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,338 Underlying: Common Stock · 11,338 shares Expires 2031-05-20 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F3 · derivative.exercise_date: Annual Retainer: Award granted in lieu of annual cash retainer payment. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 20, 2021 Filed May 21, 2021 01:00 UTC |
HOOPER ANTHONY CDirector
|
GrantRestricted Stock Unit · Derivative | 33,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034719 · doc4.xml · derivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,860 Underlying: Common Stock · 33,860 shares Expires 2031-05-20 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC |
Tross Stuart AChief People & Workpl Officer
|
GrantRestricted Stock Unit | 79,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034456 · doc4.xml · nonDerivative · entry 2 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 629,708 F3 · shares: The restricted stock unit will vest on May 17, 2024 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 17, 2021. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 18, 2021 until May 17, 2024 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC |
Tross Stuart AChief People & Workpl Officer
|
GrantRestricted Stock Unit | 68,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034456 · doc4.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,708 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC |
Kocinsky JosephChief Technology Officer
|
GrantRestricted Stock Unit | 79,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034460 · doc4.xml · nonDerivative · entry 2 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573,412 F3 · shares: The restricted stock unit will vest on May 17, 2024 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 17, 2021. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 18, 2021 until May 17, 2024 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC |
Kocinsky JosephChief Technology Officer
|
GrantRestricted Stock Unit | 68,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034460 · doc4.xml · nonDerivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,412 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
GrantRestricted Stock Unit | 79,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034453 · doc4.xml · nonDerivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 571,491 F3 · shares: The restricted stock unit will vest on May 17, 2024 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 17, 2021. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 18, 2021 until May 17, 2024 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
GrantRestricted Stock Unit | 69,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034453 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,491 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC |
Binder Steven B.Chief Financial Officer
|
GrantRestricted Stock Unit | 79,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034454 · doc4.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 546,896 F3 · shares: The restricted stock unit will vest on May 17, 2024 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 17, 2021. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 18, 2021 until May 17, 2024 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC |
Binder Steven B.Chief Financial Officer
|
GrantRestricted Stock Unit | 69,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034454 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 467,896 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
GrantRestricted Stock Unit | 226,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034452 · doc4.xml · nonDerivative · entry 2 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,533,652 F3 · shares: The restricted stock unit will vest on May 17, 2024 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 17, 2021. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 18, 2021 until May 17, 2024 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
GrantRestricted Stock Unit | 190,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034452 · doc4.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,307,652 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC |
Galindo AlejandroChief Commercial Officer
|
GrantRestricted Stock Unit | 79,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034451 · doc4.xml · nonDerivative · entry 2 Galindo Alejandro · CIK 0001821447 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 542,602 F3 · shares: The restricted stock unit will vest on May 17, 2024 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 17, 2021. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 18, 2021 until May 17, 2024 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC |
Galindo AlejandroChief Commercial Officer
|
GrantRestricted Stock Unit | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034451 · doc4.xml · nonDerivative · entry 1 Galindo Alejandro · CIK 0001821447 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463,602 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 22:00 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
PurchaseCommon Stock,$.01 par value | 3,000 | $3.38 | $10,140.00 |
DisclosureSEC source: 0001209191-21-018600 · doc4.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3,000 Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 23:18 UTC |
Binder Steven B.Chief Financial Officer
|
PurchaseCommon Stock, $0.01 Par Value | 1,557 | $1.33 | $2,070.81 |
DisclosureSEC source: 0001209191-21-006886 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,822 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective January 31, 2021. Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 23:18 UTC |
Tross Stuart AChief People & Workpl Officer
|
PurchaseCommon Stock, $0.01 Par Value | 5,000 | $1.33 | $6,650.00 |
DisclosureSEC source: 0001209191-21-006890 · doc4.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 481,991 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective January 31, 2021 representing the maximum allowable under the Plan for this period. Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 23:18 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
PurchaseCommon Stock, $0.01 Par Value | 5,000 | $1.33 | $6,650.00 |
DisclosureSEC source: 0001209191-21-006887 · doc4.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,117,560 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective January 31, 2021 representing the maximum allowable under the Plan for this period. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 23:10 UTC |
Tross Stuart AChief People & Workpl Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 1,729 | $3.33 | $5,757.57 |
DisclosureSEC source: 0001209191-20-065575 · doc4.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476,991 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 23:57 UTC Amendment |
Galindo AlejandroChief Commercial Officer
|
PurchaseCommon Stock, $0.01 Par Value | 34,602 | $2.89 | $99,999.78 |
DisclosureSEC source: 0001209191-20-062790 · doc4a.xml · nonDerivative · entry 1 Galindo Alejandro · CIK 0001821447 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,602 Read SEC document |
| December 01, 2020 Filed Dec 10, 2020 22:06 UTC |
Kay SabrinaDirector
|
GrantRestricted Stock Unit · Derivative | 44,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-062748 · doc4.xml · derivative · entry 1 Kay Sabrina · CIK 0001835895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,117 Underlying: Common Stock · 44,117 shares Expires 2030-12-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Pro-rated Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.